Higher Frequency of Certain Cancers in LRRK2 G2019S Mutation Carriers With Parkinson Disease

Importance  Patients with Parkinson disease (PD) who harbor LRRK2 G2019S mutations may have increased risks of nonskin cancers. However, the results have been inconsistent across studies. Objectives  To analyze pooled data from 5 centers to further examine the association between … Continued

Source: JAMA Oncology - November 20, 2014 Category: Cancer & Oncology Authors: Ilir Agalliu, MD, ScD and colleagues Tags: JAMA Neurology Original Investigation Research Source Type: research